Click for best price
HospitalAcquired Infection Control Market Size, Share 2024
| Market size in 2023 |
US$ 5378.2 million
|
Forecast Market size by 2030 |
US$ 6651.6 million
|
| Growth Rate |
CAGR of 3.1% |
Number of Pages |
84 Pages |
The global Hospital-Acquired Infection Control market was valued at US$ 5378.2 million in 2023 and is projected to reach US$ 6651.6 million by 2030, at a CAGR of 3.1% during the forecast period.
This research report provides a comprehensive analysis of the Hospital-Acquired Infection Control market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Hospital-Acquired Infection Control market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Hospital-Acquired Infection Control, challenges faced by the industry, and potential opportunities for market players.
The global Hospital-Acquired Infection Control market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Hospital-Acquired Infection Control market presents opportunities for various stakeholders, including Hospitals and ICUs, Outpatient Care Centers. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Hospital-Acquired Infection Control market. Additionally, the growing consumer demand present avenues for market expansion.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets.
The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The research report on the Hospital-Acquired Infection Control market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Hospital-Acquired Infection Control market.
Market Overview: The report provides a comprehensive overview of the Hospital-Acquired Infection Control market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Catheter-associated Urinary Tract Infections (CAUTIs), Surgical Site Infections (SSIs)), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Hospital-Acquired Infection Control market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Hospital-Acquired Infection Control market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Hospital-Acquired Infection Control market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Hospital-Acquired Infection Control market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Hospital-Acquired Infection Control market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Hospital-Acquired Infection Control market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Hospital-Acquired Infection Control, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Hospital-Acquired Infection Control market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Hospital-Acquired Infection Control market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Catheter-associated Urinary Tract Infections (CAUTIs)
- Surgical Site Infections (SSIs)
- Central Line-associated Bloodstream Infections (CLABSIs)
- Respiratory Infections
Market segment by Application
- Hospitals and ICUs
- Outpatient Care Centers
- Long-term Care Facilities (LTCFs)
Global Hospital-Acquired Infection Control Market Segment Percentages, By Region and Country, 2023 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Major players covered
- GSK
- Merck
- Pfizer
- 3M
- Abbott
- BD
- Cepheid
- Getinge Group
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hospital-Acquired Infection Control, market overview.
Chapter 2: Global Hospital-Acquired Infection Control market size in revenue.
Chapter 3: Detailed analysis of Hospital-Acquired Infection Control company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hospital-Acquired Infection Control in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Hospital-Acquired Infection Control Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 5378.2 million
|
| Forecast Market size by 2030 |
US$ 6651.6 million
|
| Growth Rate |
CAGR of 3.1% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
84 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hospital-Acquired Infection Control Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hospital-Acquired Infection Control Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hospital-Acquired Infection Control Overall Market Size
2.1 Global Hospital-Acquired Infection Control Market Size: 2023 VS 2030
2.2 Global Hospital-Acquired Infection Control Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hospital-Acquired Infection Control Players in Global Market
3.2 Top Global Hospital-Acquired Infection Control Companies Ranked by Revenue
3.3 Global Hospital-Acquired Infection Control Revenue by Companies
3.4 Top 3 and Top 5 Hospital-Acquired Infection Control Companies in Global Market, by Revenue in 2023
3.5 Global Companies Hospital-Acquired Infection Control Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hospital-Acquired Infection Control Players in Global Market
3.6.1 List of Global Tier 1 Hospital-Acquired Infection Control Companies
3.6.2 List of Global Tier 2 and Tier 3 Hospital-Acquired Infection Control Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hospital-Acquired Infection Control Market Size Markets, 2023 & 2030
4.1.2 Catheter-associated Urinary Tract Infections (CAUTIs)
4.1.3 Surgical Site Infections (SSIs)
4.1.4 Central Line-associated Bloodstream Infections (CLABSIs)
4.1.5 Respiratory Infections
4.2 By Type - Global Hospital-Acquired Infection Control Revenue & Forecasts
4.2.1 By Type - Global Hospital-Acquired Infection Control Revenue, 2019-2024
4.2.2 By Type - Global Hospital-Acquired Infection Control Revenue, 2025-2030
4.2.3 By Type - Global Hospital-Acquired Infection Control Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hospital-Acquired Infection Control Market Size, 2023 & 2030
5.1.2 Hospitals and ICUs
5.1.3 Outpatient Care Centers
5.1.4 Long-term Care Facilities (LTCFs)
5.2 By Application - Global Hospital-Acquired Infection Control Revenue & Forecasts
5.2.1 By Application - Global Hospital-Acquired Infection Control Revenue, 2019-2024
5.2.2 By Application - Global Hospital-Acquired Infection Control Revenue, 2025-2030
5.2.3 By Application - Global Hospital-Acquired Infection Control Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Hospital-Acquired Infection Control Market Size, 2023 & 2030
6.2 By Region - Global Hospital-Acquired Infection Control Revenue & Forecasts
6.2.1 By Region - Global Hospital-Acquired Infection Control Revenue, 2019-2024
6.2.2 By Region - Global Hospital-Acquired Infection Control Revenue, 2025-2030
6.2.3 By Region - Global Hospital-Acquired Infection Control Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Hospital-Acquired Infection Control Revenue, 2019-2030
6.3.2 US Hospital-Acquired Infection Control Market Size, 2019-2030
6.3.3 Canada Hospital-Acquired Infection Control Market Size, 2019-2030
6.3.4 Mexico Hospital-Acquired Infection Control Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Hospital-Acquired Infection Control Revenue, 2019-2030
6.4.2 Germany Hospital-Acquired Infection Control Market Size, 2019-2030
6.4.3 France Hospital-Acquired Infection Control Market Size, 2019-2030
6.4.4 U.K. Hospital-Acquired Infection Control Market Size, 2019-2030
6.4.5 Italy Hospital-Acquired Infection Control Market Size, 2019-2030
6.4.6 Russia Hospital-Acquired Infection Control Market Size, 2019-2030
6.4.7 Nordic Countries Hospital-Acquired Infection Control Market Size, 2019-2030
6.4.8 Benelux Hospital-Acquired Infection Control Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Hospital-Acquired Infection Control Revenue, 2019-2030
6.5.2 China Hospital-Acquired Infection Control Market Size, 2019-2030
6.5.3 Japan Hospital-Acquired Infection Control Market Size, 2019-2030
6.5.4 South Korea Hospital-Acquired Infection Control Market Size, 2019-2030
6.5.5 Southeast Asia Hospital-Acquired Infection Control Market Size, 2019-2030
6.5.6 India Hospital-Acquired Infection Control Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Hospital-Acquired Infection Control Revenue, 2019-2030
6.6.2 Brazil Hospital-Acquired Infection Control Market Size, 2019-2030
6.6.3 Argentina Hospital-Acquired Infection Control Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hospital-Acquired Infection Control Revenue, 2019-2030
6.7.2 Turkey Hospital-Acquired Infection Control Market Size, 2019-2030
6.7.3 Israel Hospital-Acquired Infection Control Market Size, 2019-2030
6.7.4 Saudi Arabia Hospital-Acquired Infection Control Market Size, 2019-2030
6.7.5 UAE Hospital-Acquired Infection Control Market Size, 2019-2030
7 Hospital-Acquired Infection Control Companies Profiles
7.1 GSK
7.1.1 GSK Company Summary
7.1.2 GSK Business Overview
7.1.3 GSK Hospital-Acquired Infection Control Major Product Offerings
7.1.4 GSK Hospital-Acquired Infection Control Revenue in Global Market (2019-2024)
7.1.5 GSK Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Hospital-Acquired Infection Control Major Product Offerings
7.2.4 Merck Hospital-Acquired Infection Control Revenue in Global Market (2019-2024)
7.2.5 Merck Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Hospital-Acquired Infection Control Major Product Offerings
7.3.4 Pfizer Hospital-Acquired Infection Control Revenue in Global Market (2019-2024)
7.3.5 Pfizer Key News & Latest Developments
7.4 3M
7.4.1 3M Company Summary
7.4.2 3M Business Overview
7.4.3 3M Hospital-Acquired Infection Control Major Product Offerings
7.4.4 3M Hospital-Acquired Infection Control Revenue in Global Market (2019-2024)
7.4.5 3M Key News & Latest Developments
7.5 Abbott
7.5.1 Abbott Company Summary
7.5.2 Abbott Business Overview
7.5.3 Abbott Hospital-Acquired Infection Control Major Product Offerings
7.5.4 Abbott Hospital-Acquired Infection Control Revenue in Global Market (2019-2024)
7.5.5 Abbott Key News & Latest Developments
7.6 BD
7.6.1 BD Company Summary
7.6.2 BD Business Overview
7.6.3 BD Hospital-Acquired Infection Control Major Product Offerings
7.6.4 BD Hospital-Acquired Infection Control Revenue in Global Market (2019-2024)
7.6.5 BD Key News & Latest Developments
7.7 Cepheid
7.7.1 Cepheid Company Summary
7.7.2 Cepheid Business Overview
7.7.3 Cepheid Hospital-Acquired Infection Control Major Product Offerings
7.7.4 Cepheid Hospital-Acquired Infection Control Revenue in Global Market (2019-2024)
7.7.5 Cepheid Key News & Latest Developments
7.8 Getinge Group
7.8.1 Getinge Group Company Summary
7.8.2 Getinge Group Business Overview
7.8.3 Getinge Group Hospital-Acquired Infection Control Major Product Offerings
7.8.4 Getinge Group Hospital-Acquired Infection Control Revenue in Global Market (2019-2024)
7.8.5 Getinge Group Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Hospital-Acquired Infection Control Market Opportunities & Trends in Global Market
Table 2. Hospital-Acquired Infection Control Market Drivers in Global Market
Table 3. Hospital-Acquired Infection Control Market Restraints in Global Market
Table 4. Key Players of Hospital-Acquired Infection Control in Global Market
Table 5. Top Hospital-Acquired Infection Control Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Hospital-Acquired Infection Control Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Hospital-Acquired Infection Control Revenue Share by Companies, 2019-2024
Table 8. Global Companies Hospital-Acquired Infection Control Product Type
Table 9. List of Global Tier 1 Hospital-Acquired Infection Control Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hospital-Acquired Infection Control Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Hospital-Acquired Infection Control Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Hospital-Acquired Infection Control Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Hospital-Acquired Infection Control Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Hospital-Acquired Infection Control Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Hospital-Acquired Infection Control Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Hospital-Acquired Infection Control Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Hospital-Acquired Infection Control Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Hospital-Acquired Infection Control Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Hospital-Acquired Infection Control Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Hospital-Acquired Infection Control Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Hospital-Acquired Infection Control Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Hospital-Acquired Infection Control Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Hospital-Acquired Infection Control Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Hospital-Acquired Infection Control Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Hospital-Acquired Infection Control Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Hospital-Acquired Infection Control Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Hospital-Acquired Infection Control Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Hospital-Acquired Infection Control Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Hospital-Acquired Infection Control Revenue, (US$, Mn), 2025-2030
Table 30. GSK Company Summary
Table 31. GSK Hospital-Acquired Infection Control Product Offerings
Table 32. GSK Hospital-Acquired Infection Control Revenue (US$, Mn) & (2019-2024)
Table 33. GSK Key News & Latest Developments
Table 34. Merck Company Summary
Table 35. Merck Hospital-Acquired Infection Control Product Offerings
Table 36. Merck Hospital-Acquired Infection Control Revenue (US$, Mn) & (2019-2024)
Table 37. Merck Key News & Latest Developments
Table 38. Pfizer Company Summary
Table 39. Pfizer Hospital-Acquired Infection Control Product Offerings
Table 40. Pfizer Hospital-Acquired Infection Control Revenue (US$, Mn) & (2019-2024)
Table 41. Pfizer Key News & Latest Developments
Table 42. 3M Company Summary
Table 43. 3M Hospital-Acquired Infection Control Product Offerings
Table 44. 3M Hospital-Acquired Infection Control Revenue (US$, Mn) & (2019-2024)
Table 45. 3M Key News & Latest Developments
Table 46. Abbott Company Summary
Table 47. Abbott Hospital-Acquired Infection Control Product Offerings
Table 48. Abbott Hospital-Acquired Infection Control Revenue (US$, Mn) & (2019-2024)
Table 49. Abbott Key News & Latest Developments
Table 50. BD Company Summary
Table 51. BD Hospital-Acquired Infection Control Product Offerings
Table 52. BD Hospital-Acquired Infection Control Revenue (US$, Mn) & (2019-2024)
Table 53. BD Key News & Latest Developments
Table 54. Cepheid Company Summary
Table 55. Cepheid Hospital-Acquired Infection Control Product Offerings
Table 56. Cepheid Hospital-Acquired Infection Control Revenue (US$, Mn) & (2019-2024)
Table 57. Cepheid Key News & Latest Developments
Table 58. Getinge Group Company Summary
Table 59. Getinge Group Hospital-Acquired Infection Control Product Offerings
Table 60. Getinge Group Hospital-Acquired Infection Control Revenue (US$, Mn) & (2019-2024)
Table 61. Getinge Group Key News & Latest Developments
List of Figures
Figure 1. Hospital-Acquired Infection Control Segment by Type in 2023
Figure 2. Hospital-Acquired Infection Control Segment by Application in 2023
Figure 3. Global Hospital-Acquired Infection Control Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Hospital-Acquired Infection Control Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Hospital-Acquired Infection Control Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hospital-Acquired Infection Control Revenue in 2023
Figure 8. By Type - Global Hospital-Acquired Infection Control Revenue Market Share, 2019-2030
Figure 9. By Application - Global Hospital-Acquired Infection Control Revenue Market Share, 2019-2030
Figure 10. By Type - Global Hospital-Acquired Infection Control Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Hospital-Acquired Infection Control Revenue Market Share, 2019-2030
Figure 12. By Application - Global Hospital-Acquired Infection Control Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Hospital-Acquired Infection Control Revenue Market Share, 2019-2030
Figure 14. By Region - Global Hospital-Acquired Infection Control Revenue Market Share, 2019-2030
Figure 15. By Country - North America Hospital-Acquired Infection Control Revenue Market Share, 2019-2030
Figure 16. US Hospital-Acquired Infection Control Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Hospital-Acquired Infection Control Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Hospital-Acquired Infection Control Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Hospital-Acquired Infection Control Revenue Market Share, 2019-2030
Figure 20. Germany Hospital-Acquired Infection Control Revenue, (US$, Mn), 2019-2030
Figure 21. France Hospital-Acquired Infection Control Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Hospital-Acquired Infection Control Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Hospital-Acquired Infection Control Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Hospital-Acquired Infection Control Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Hospital-Acquired Infection Control Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Hospital-Acquired Infection Control Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Hospital-Acquired Infection Control Revenue Market Share, 2019-2030
Figure 28. China Hospital-Acquired Infection Control Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Hospital-Acquired Infection Control Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Hospital-Acquired Infection Control Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Hospital-Acquired Infection Control Revenue, (US$, Mn), 2019-2030
Figure 32. India Hospital-Acquired Infection Control Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Hospital-Acquired Infection Control Revenue Market Share, 2019-2030
Figure 34. Brazil Hospital-Acquired Infection Control Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Hospital-Acquired Infection Control Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Hospital-Acquired Infection Control Revenue Market Share, 2019-2030
Figure 37. Turkey Hospital-Acquired Infection Control Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Hospital-Acquired Infection Control Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Hospital-Acquired Infection Control Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Hospital-Acquired Infection Control Revenue, (US$, Mn), 2019-2030
Figure 41. GSK Hospital-Acquired Infection Control Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Merck Hospital-Acquired Infection Control Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Pfizer Hospital-Acquired Infection Control Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. 3M Hospital-Acquired Infection Control Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Abbott Hospital-Acquired Infection Control Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. BD Hospital-Acquired Infection Control Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Cepheid Hospital-Acquired Infection Control Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Getinge Group Hospital-Acquired Infection Control Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
